EXPD vs LYEL · P/E 26, rev $6.29B vs rev $6.0K
Expeditors International of Washington, Inc. (EXPD) versus Lyell Immunopharma Inc (LYEL) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Latest reported EXPD revenue for 2026-06-30 was $6.29B. Net income was $495.8M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. LYEL currently screens at market cap $143.5M.
Not investment advice. Open the EXPD and LYEL stock pages for the full models.
Not investment advice.